HK Stock MarketDetailed Quotes

06833 SINCO PHARMA

Watchlist
  • 0.260
  • 0.0000.00%
Market Closed Mar 28 16:08 CST
528.55MMarket Cap11.30P/E (TTM)

About SINCO PHARMA Company

As a leading marketing, promotion and channel management service provider, the Group focuses on blood products with rich experience in imported pharmaceutical distribution, and provides comprehensive marketing, promotion and channel management services to overseas small and medium-sized pharmaceutical companies based on a marketing and promotion network covering the whole of China. The Group's products are imported from well-known overseas pharmaceutical companies, and the product portfolio mainly covers prescription drugs such as blood products and anti-infective drugs. The marketing and promotion services provided by the Group include: coordinating and cooperating with overseas pharmaceutical companies to carry out import registration/re-registration work and other regulatory agency requirements; formulating customized marketing and marketing strategies based on consideration of product treatment fields, product characteristics, regulatory environment, market needs and other commercial factors; selecting, appointing and managing third party service promoters; organizing academic conferences, lectures, seminars and other promotional activities; and communicating to physicians about the medical uses and benefits of the Group's products. The channel management services provided by the Group include: customs clearance and inspection of products; cooperation with third parties to carry out logistics distribution work; participation in tenders; confirmation of purchase orders, product delivery and collection work of third party commercial pharmaceutical distribution companies; collection and analysis of sales data; and management and improvement of the inventory volume of commercial distribution channels. The Group selects high-quality blood products from overseas markets to make up for the pharmaceutical needs that have yet to be met in the domestic market; with the excellent clinical effects of the products, it ensures that it has strong growth potential in the Chinese pharmaceutical industry. The Group is also continuing to promote industrial deployment in the medical and aesthetic field. While medical and aesthetic R&D projects are progressing steadily, the Group's product production line construction and medical and aesthetic team recruitment have all been carried out smoothly in the first half of 2022.

Company Profile

Symbol06833
Company NameSINCO PHARMA
ISINKYG8154Y1052
Listing Date03/10/2016
Issue Price0.80
Shares Offered400.00M share
Founded03/16/2015
RegistrationCayman Islands
ChairmanXiangbin Huang
SecretaryYunlu Peng
Audit InstitutionPioneer Accountants Ltd
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficePO Box 309 Ugland House Grand Cayman, KY1-1104 Cayman Islands
Head Office and Principal Place of BusinessRoom 2403, Wing On Centre, 111 Connaught Road Central, Hong Kong
Fiscal Year Ends12-31
Employees278
MarketHong Kong motherboard
Phone+852 2960 9692
Fax+852 2960 1633
Emailsinco-pharm@sinco-pharm.cn
Business Xing Kerong Pharmaceutical Holdings Co., Ltd. mainly provides marketing, promotion and channel management (MPCM) services in the pharmaceutical industry of the People's Republic of China (China). The company provides comprehensive MPCM services to small and medium-sized overseas pharmaceutical manufacturers that do not have independent marketing and promotion capabilities in China. Its main product is human serum protein injection. This product is a human serum protein manufactured by Octapharma to treat hypovolemia and hypovolemic shock, abnormally high intracranial pressure, edema, and ascites, and the prevention and treatment of hypoalbuminemia and neonatal hyperbilirubinemia. In addition, its products include Enkoxin, McDowb, Alsaffin, Tate, and Tarot.

Company Executives

  • Name
  • Position
  • Salary
  • Xiangbin Huang
  • Nomination Committee Chairman,Executive Director,Authorized Representative,Chairman
  • --
  • Yingjie Liu
  • Independent Non-Executive Director,Audit Committee Chairman,Nomination Committee Member
  • --
  • Qing Wang
  • Remuneration Committee Chairman,Independent Non-Executive Director,Audit Committee Member
  • --
  • Wenfang Liu
  • Nomination Committee Member,Independent Non-Executive Director,Audit Committee Member,Remuneration Committee Member
  • --
  • Zhizhong Bai
  • Remuneration Committee Member,Independent Non-Executive Director,Audit Committee Member
  • --
  • Min Jin
  • CEO
  • --
  • Yifan Li
  • CFO
  • --
  • Shifeng Lei
  • Executive Director,Remuneration Committee Member
  • --
  • Yunlu Peng
  • Authorized Representative,Company Secretary
  • --
  • Zhijian Huang
  • Executive Director
  • --
  • Tao Zhang
  • Chairman of Sichuan Xingkerong Pharmaceutical Co., Ltd.
  • --
  • Qingjiang Wu
  • Served as the general manager of Chengdu Hengmeisheng Biotechnology Co., Ltd.,VP
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg